HomeMarkets Markets Big pharma says drug prices reflect R&D cost. Researchers call BS By news October 15, 2022 0 141 FacebookTwitterPinterestWhatsApp A new study finds no correlation between R&D spending and outlandish drug prices. At the end of September, a spot of good news: Relyvrio, a new drug …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected156,253FansLike396,312FollowersFollow2,340SubscribersSubscribe Latest Articles Markets Mapped: Wildfires in Los Angeles, and the Current Situation Markets AMD stock ‘falling off a cliff’; Should you buy? Biotech Raymond James Predicts Up to ~930% Rally for These 2 ‘Strong Buy’ Stocks News Secretary of defense must perform a ‘delicate dance’ between the president, Congress and the public Markets Cabinet profile News, Research and Analysis – The Conversation Markets Zuckerberg distances from former allies in Joe Rogan interview Climate Wildfires can contaminate drinking water systems with harmful chemicals − here’s what Los Angeles needs to know Top Trades PhilStockWorld Top Trade Alert – Jan 10 2025 – First Trust Natural Gas (FCG) Markets Fire Fighting Friday – Tragedy in Los Angeles County Markets Playing Jenga with Maritime Shipping Markets Trump may receive an ‘unconditional discharge’ in hush money conviction − a constitutional law expert explains what that means News The Army of God Comes Out of the Shadows (shared) Markets Trump’s Greenland bid is really about control of the Arctic and the coming battle with China Climate How the world fell in love with plastic without thinking through the consequences Load more